Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of AnaptysBio Inc (NASDAQ: ANAB) closed at $42.16 in the last session, up 1.59% from day before closing price of $41.5. In other words, the price has increased by $1.59 from its previous closing price. On the day, 0.58 million shares were traded. ANAB stock price reached its highest trading level at $42.81 during the session, while it also had its lowest trading level at $41.1466.
Ratios:
We take a closer look at ANAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.68 and its Current Ratio is at 8.68.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on October 13, 2025, initiated with a Overweight rating and assigned the stock a target price of $78.
On June 04, 2025, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $38.
On February 04, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $25.Wolfe Research initiated its Outperform rating on February 04, 2025, with a $25 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 30 ’25 when LOUMEAU ERIC J sold 8,240 shares for $29.00 per share. The transaction valued at 238,960 led to the insider holds 9,088 shares of the business.
ERIC J LOUMEAU bought 8,240 shares of ANAB for $238,960 on Sep 30 ’25. On Aug 08 ’25, another insider, RENTON HOLLINGS, who serves as the Director of the company, sold 10,231 shares for $19.62 each. As a result, the insider received 200,714 and left with 4,965 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 1179341568 and an Enterprise Value of 1264839936. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.89. Its current Enterprise Value per Revenue stands at 7.464 whereas that against EBITDA is -45.009.
Stock Price History:
The Beta on a monthly basis for ANAB is 0.28, which has changed by 0.68910253 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, ANAB has reached a high of $43.31, while it has fallen to a 52-week low of $12.21. The 50-Day Moving Average of the stock is 28.50%, while the 200-Day Moving Average is calculated to be 76.42%.
Shares Statistics:
According to the various share statistics, ANAB traded on average about 605.56K shares per day over the past 3-months and 810370 shares per day over the past 10 days. A total of 27.58M shares are outstanding, with a floating share count of 26.04M. Insiders hold about 5.95% of the company’s shares, while institutions hold 112.63% stake in the company. Shares short for ANAB as of 1763078400 were 5930320 with a Short Ratio of 9.79, compared to 1760486400 on 7105715. Therefore, it implies a Short% of Shares Outstanding of 5930320 and a Short% of Float of 40.65.
Earnings Estimates
As of right now, 8.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$1.03, with high estimates of -$0.46 and low estimates of -$1.78.
Analysts are recommending an EPS of between -$0.49 and -$3.66 for the fiscal current year, implying an average EPS of -$1.47. EPS for the following year is -$3.95, with 8.0 analysts recommending between $1.1 and -$7.83.
Revenue Estimates
According to 9 analysts,. The current quarter’s revenue is expected to be $86.15M. It ranges from a high estimate of $104.3M to a low estimate of $36M. As of. The current estimate, AnaptysBio Inc’s year-ago sales were $43.11M
A total of 9 analysts have provided revenue estimates for ANAB’s current fiscal year. The highest revenue estimate was $230.6M, while the lowest revenue estimate was $148M, resulting in an average revenue estimate of $202.57M. In the same quarter a year ago, actual revenue was $91.28M
